Mon 30 Nov 2009 | 3:25 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Cypress Bioscience Inc

Cypress Bioscience Inc (CYPB.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty ยท View CYPB on other exchanges
As of  27 Nov 2009
5.40USD
Price Change
-0.23
Percent Change
-4.09%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 30 Dec 2008
Gendreau, R. Michael 367,320 -- 15,500 685,516
Hawley, Roger -- -- -- --
Johnson, Sabrina 373,875 -- 15,500 795,551
Kalali, Amir -- -- -- --
Kranzler, Jay 848,033 -- 37,439 3,610,730
McGarity, Jon -- -- -- --
Millon, Jean-Pierre -- -- -- --
Molinoff, Perry -- -- -- --
Nova, Tina -- -- -- --
Petree, Daniel -- -- -- --
Rao, Srinivas 286,510 -- 15,500 555,006
Walsh, Michael 311,250 -- 15,500 853,200
Wheeler, Denise 205,219 -- 15,500 582,458